Product Information
PYRIDOSTIGMINE BR 60 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.2487 per EA under NDC 00115351101. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 24, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115351101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040502FDA Approved
4/24/2003
TE Code
AB
On Market Since
4/24/2003
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2487 per EA |
|---|---|
| All-time high | $0.6549 (Oct 14, 2015) |
| All-time low | $0.1867 (Nov 20, 2024) |
| 52-week high | $0.2753 |
| 52-week low | $0.2487 |
| Median price | $0.3386 |
| Average price | $0.3617 |
| Largest weekly change | +52.5% (Apr 22, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PYRIDOSTIGMINE BROMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PYRIDOSTIGMINE BROMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE BR 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE BR 60 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.2487 per EA (NDC 00115351101), effective Sep 30, 2026.
How has the price of PYRIDOSTIGMINE BR 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has declined 6.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE BR 60 MG TABLET?
Since Nov 28, 2013, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has ranged from a low of $0.1867 (Nov 20, 2024) to a high of $0.6549 (Oct 14, 2015), with a median of $0.3386 per EA.
Are there cheaper alternatives to PYRIDOSTIGMINE BR 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PYRIDOSTIGMINE BR 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PYRIDOSTIGMINE BR 60 MG TABLET?
PYRIDOSTIGMINE BR 60 MG TABLET (NDC 00115351101) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.